Sharma R, Incoronato A, Zhang C, Jayanthan A, et al. Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia. J Pediatr Hematol Oncol 2023;45:e750-e756.
PMID: 37494611